199 related articles for article (PubMed ID: 16288748)
21. Induction of apoptosis in human cells by RNAi-mediated knockdown of hARD1 and NATH, components of the protein N-alpha-acetyltransferase complex.
Arnesen T; Gromyko D; Pendino F; Ryningen A; Varhaug JE; Lillehaug JR
Oncogene; 2006 Jul; 25(31):4350-60. PubMed ID: 16518407
[TBL] [Abstract][Full Text] [Related]
22. A novel human NatA Nalpha-terminal acetyltransferase complex: hNaa16p-hNaa10p (hNat2-hArd1).
Arnesen T; Gromyko D; Kagabo D; Betts MJ; Starheim KK; Varhaug JE; Anderson D; Lillehaug JR
BMC Biochem; 2009 May; 10():15. PubMed ID: 19480662
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the native and fibrillar conformation of the human Nalpha-acetyltransferase ARD1.
Sánchez-Puig N; Fersht AR
Protein Sci; 2006 Aug; 15(8):1968-76. PubMed ID: 16823041
[TBL] [Abstract][Full Text] [Related]
24. Differential regulation of splicing, localization and stability of mammalian ARD1235 and ARD1225 isoforms.
Chun KH; Cho SJ; Choi JS; Kim SH; Kim KW; Lee SK
Biochem Biophys Res Commun; 2007 Feb; 353(1):18-25. PubMed ID: 17161380
[TBL] [Abstract][Full Text] [Related]
25. Arrest defective 1 autoacetylation is a critical step in its ability to stimulate cancer cell proliferation.
Seo JH; Cha JH; Park JH; Jeong CH; Park ZY; Lee HS; Oh SH; Kang JH; Suh SW; Kim KH; Ha JY; Han SH; Kim SH; Lee JW; Park JA; Jeong JW; Lee KJ; Oh GT; Lee MN; Kwon SW; Lee SK; Chun KH; Lee SJ; Kim KW
Cancer Res; 2010 Jun; 70(11):4422-32. PubMed ID: 20501853
[TBL] [Abstract][Full Text] [Related]
26. Differential responses of two degradation domains of HIF-1alpha to hypoxia and iron deficiency.
Lee KH; Choi E; Chun YS; Kim MS; Park JW
Biochimie; 2006 Feb; 88(2):163-9. PubMed ID: 16139409
[TBL] [Abstract][Full Text] [Related]
27. The N-terminal Acetyltransferase Naa10/ARD1 Does Not Acetylate Lysine Residues.
Magin RS; March ZM; Marmorstein R
J Biol Chem; 2016 Mar; 291(10):5270-7. PubMed ID: 26755727
[TBL] [Abstract][Full Text] [Related]
28. [Production of anti-recombinant human arrest defective 1 protein (hARD1) monoclonal antibodies for assaying human breast cancer tissues].
Yu M; Wang Z; Gong J; Ma M; Jiao Y; Huang W; Lü Q; Li L; Yang H; Tan D
Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):57-62. PubMed ID: 20353093
[TBL] [Abstract][Full Text] [Related]
29. Ubiquitination is absolutely required for the degradation of hypoxia-inducible factor--1 alpha protein in hypoxic conditions.
Wang R; Zhang P; Li J; Guan H; Shi G
Biochem Biophys Res Commun; 2016 Jan; 470(1):117-122. PubMed ID: 26766791
[TBL] [Abstract][Full Text] [Related]
30. Nuclear translocation of hARD1 contributes to proper cell cycle progression.
Park JH; Seo JH; Wee HJ; Vo TT; Lee EJ; Choi H; Cha JH; Ahn BJ; Shin MW; Bae SJ; Kim KW
PLoS One; 2014; 9(8):e105185. PubMed ID: 25133627
[TBL] [Abstract][Full Text] [Related]
31. N-acetyltransferase ARD1-NAT1 regulates neuronal dendritic development.
Ohkawa N; Sugisaki S; Tokunaga E; Fujitani K; Hayasaka T; Setou M; Inokuchi K
Genes Cells; 2008 Nov; 13(11):1171-83. PubMed ID: 19090811
[TBL] [Abstract][Full Text] [Related]
32. Hydroxylation of the Acetyltransferase NAA10 Trp38 Is Not an Enzyme-Switch in Human Cells.
Ree R; Krogstad K; McTiernan N; Jakobsson ME; Arnesen T
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769235
[TBL] [Abstract][Full Text] [Related]
33. Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization.
Fischer C; Leithner K; Wohlkoenig C; Quehenberger F; Bertsch A; Olschewski A; Olschewski H; Hrzenjak A
Mol Cancer; 2015 Jan; 14():4. PubMed ID: 25608569
[TBL] [Abstract][Full Text] [Related]
34. ARD1 binding to RIP1 mediates doxorubicin-induced NF-κB activation.
Park J; Kanayama A; Yamamoto K; Miyamoto Y
Biochem Biophys Res Commun; 2012 Jun; 422(2):291-7. PubMed ID: 22580278
[TBL] [Abstract][Full Text] [Related]
35. SIRT1 deacetylates and stabilizes hypoxia-inducible factor-1α (HIF-1α) via direct interactions during hypoxia.
Joo HY; Yun M; Jeong J; Park ER; Shin HJ; Woo SR; Jung JK; Kim YM; Park JJ; Kim J; Lee KH
Biochem Biophys Res Commun; 2015 Jul; 462(4):294-300. PubMed ID: 25979359
[TBL] [Abstract][Full Text] [Related]
36. K63-polyubiquitinated HAUSP deubiquitinates HIF-1α and dictates H3K56 acetylation promoting hypoxia-induced tumour progression.
Wu HT; Kuo YC; Hung JJ; Huang CH; Chen WY; Chou TY; Chen Y; Chen YJ; Chen YJ; Cheng WC; Teng SC; Wu KJ
Nat Commun; 2016 Dec; 7():13644. PubMed ID: 27934968
[TBL] [Abstract][Full Text] [Related]
37. Characterization of an oxygen/redox-dependent degradation domain of hypoxia-inducible factor alpha (HIF-alpha) proteins.
Srinivas V; Zhang LP; Zhu XH; Caro J
Biochem Biophys Res Commun; 1999 Jul; 260(2):557-61. PubMed ID: 10403805
[TBL] [Abstract][Full Text] [Related]
38. [hARD1 antiserum preparation and primary immunohistochemical analysis of hARD1 in tumor tissues].
Yu M; Huang C; Xiang M; Lai J; Yang H; Ma M; Tan D
Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1155-61. PubMed ID: 18837388
[TBL] [Abstract][Full Text] [Related]
39. Arrest defective-1 controls tumor cell behavior by acetylating myosin light chain kinase.
Shin DH; Chun YS; Lee KH; Shin HW; Park JW
PLoS One; 2009 Oct; 4(10):e7451. PubMed ID: 19826488
[TBL] [Abstract][Full Text] [Related]
40. Significance of prolyl hydroxylase 2 in the interference of aryl hydrocarbon receptor and hypoxia-inducible factor-1 alpha signaling.
Seifert A; Katschinski DM; Tonack S; Fischer B; Navarrete Santos A
Chem Res Toxicol; 2008 Feb; 21(2):341-8. PubMed ID: 18072750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
